Piramal Enterprises has received approval for the issuance of Secured, Rated, Listed, Redeemable, Non-Convertible Debentures (NCDs) up to Rs 75 crore along with the green shoe option to retain oversubscription of up to Rs 375 crore, aggregating the total issue size to Rs 450 crore, on private placement basis. The Administrative Committee of the Board of Directors of the company at their meeting held on February 13, 2025 has approved the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
